603 filings
Page 23 of 31
8-K
DARE
Dare Bioscience Inc
19 Oct 16
Cerulean Announces Technology Platform Collaboration
12:00am
424B5
DARE
Dare Bioscience Inc
18 Oct 16
Prospectus supplement for primary offering
12:00am
8-K
DARE
Dare Bioscience Inc
18 Oct 16
Common Stock Purchase Agreement
12:00am
D
DARE
Dare Bioscience Inc
17 Oct 16
$1 in options, sold $1, 1 investor
12:00am
EFFECT
DARE
Dare Bioscience Inc
14 Oct 16
Notice of effectiveness
12:00am
POS AM
DARE
Dare Bioscience Inc
13 Oct 16
Prospectus update (post-effective amendment)
12:00am
CORRESP
DARE
Dare Bioscience Inc
13 Oct 16
Correspondence with SEC
12:00am
CORRESP
DARE
Dare Bioscience Inc
13 Oct 16
Correspondence with SEC
12:00am
SC 13G/A
DARE
Dare Bioscience Inc
12 Sep 16
Cerulean Pharma Inc.
12:00am
4
DARE
Dare Bioscience Inc
23 Aug 16
Cerulean Pharma / James E ONeill ownership change
12:00am
4
DARE
Dare Bioscience Inc
23 Aug 16
Cerulean Pharma / Adrian Senderowicz ownership change
12:00am
4
Beloff Gregg
23 Aug 16
Cerulean Pharma / GREGG BELOFF ownership change
12:00am
4
DARE
Dare Bioscience Inc
23 Aug 16
Cerulean Pharma / Alejandra Carvajal ownership change
12:00am
8-K
DARE
Dare Bioscience Inc
18 Aug 16
Cerulean Announces Reduction in Force
12:00am
8-K
DARE
Dare Bioscience Inc
17 Aug 16
Cerulean Announces Results from Phase 2 Clinical Trial of CRLX101 and AvastinĀ® Combination in Relapsed Renal Cell Carcinoma
12:00am
UPLOAD
DARE
Dare Bioscience Inc
16 Aug 16
Letter from SEC
12:00am
POS AM
DARE
Dare Bioscience Inc
5 Aug 16
Prospectus update (post-effective amendment)
12:00am
10-Q
2016 Q2
DARE
Dare Bioscience Inc
Quarterly report
4 Aug 16
12:00am
8-K
DARE
Dare Bioscience Inc
4 Aug 16
Cerulean Reports Second Quarter 2016 Corporate Highlights and Financial Results
12:00am
4
DARE
Dare Bioscience Inc
8 Jul 16
Cerulean Pharma / CHRISTOPHERD T GUIFFRE ownership change
12:00am